Appointment of new Interim Chief Executive Officer for Cochrane

Cochrane ’s Governing Board is pleased to announce, with effect from 1 June 2021, the appointment of Judith Brodie as our new interim Chief Executive Officer. Judith will lead Cochrane as the organisation undergoes its search for a permanent CEO and ensure a smooth transition.Governing Board Co-Chairs, Tracey Howe and Catherine Marshall welcomed Judith ’s appointment: " Judith is a seasoned, well-respected and proven interim Chief Executive with an exceptional record in non-profit organisations and brings expertise in finance, fundraising, public and patient involvement in healthcare and marketing. Judith is a great fit for Cochrane and is well qualified to lead Cochrane as we drive a programme of change at this crucial time of global health and economic challenge. "On her appointment, Judith, said: " I am delighted to be joining Cochrane and being part of this global collaboration.   The work of Cochrane has surely never been more important.  I am looking forward to meeting and working with many of Cochrane’s Group staff and contributors and the wider network over the coming months. "The Co-Chairs added, " We would also like to record our appreciation to our Editor-in-Chief, Karla Soares-Weiser, for taking on the additional role of Acting CEO, as well as to Toby Lasserson who has been Acting Editor-in-Chief and Chris Champion who took on additional responsibilities for governance and finance. "On behalf of Cochrane ’s Governing Board, we warmly welcome Judith to th...
Source: Cochrane News and Events - Category: Information Technology Authors: Source Type: news